Yang JC - Search Results

1

Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.

Yang JC, Wang HL, Chern HD, Shun CT, Lin BR, Lin CJ, Wang TH. Yang JC, et al. Pharmacotherapy. 2011 Mar;31(3):227-38. doi: 10.1592/phco.31.3.227. Pharmacotherapy. 2011. PMID: 21361732 Clinical Trial.

2

Time-dependent amplified pharmacokinetic and pharmacodynamic responses of rabeprazole in cytochrome P450 2C19 poor metabolizers.

Lin CJ, Yang JC, Uang YS, Chern HD, Wang TH. Lin CJ, et al. Among authors: yang jc. Pharmacotherapy. 2003 Jun;23(6):711-9. doi: 10.1592/phco.23.6.711.32177. Pharmacotherapy. 2003. PMID: 12820812

3

Limited value of typical gastroesophageal reflux disease symptoms to screen for erosive esophagitis in Taiwanese.

Lin BR, Wong JM, Yang JC, Wang JT, Lin JT, Wang TH. Lin BR, et al. Among authors: yang jc. J Formos Med Assoc. 2003 May;102(5):299-304. J Formos Med Assoc. 2003. PMID: 12874667

4

Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers.

Lai YC, Yang JC, Huang SH. Lai YC, et al. Among authors: yang jc. World J Gastroenterol. 2004 Apr 1;10(7):991-4. doi: 10.3748/wjg.v10.i7.991. World J Gastroenterol. 2004. PMID: 15052680 Free PMC article. Clinical Trial.

5

Acute pancreatitis combined with acute Budd-Chiari syndrome as the initial manifestation of small cell lung cancer.

Huang YW, Yang JC, Chang YL, Tsang YM, Wang TH. Huang YW, et al. Among authors: yang jc. J Formos Med Assoc. 2005 Jun;104(6):431-5. J Formos Med Assoc. 2005. PMID: 16037834

6

Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice.

Yang JC, Shun CT, Chien CT, Wang TH. Yang JC, et al. J Nutr. 2008 Nov;138(11):2084-90. doi: 10.3945/jn.108.090985. J Nutr. 2008. PMID: 18936202

7

A new approach for the prevention and treatment of Helicobacter pylori infection via upregulation of autophagy and downregulation of apoptosis.

Yang JC, Chien CT. Yang JC, et al. Autophagy. 2009 Apr;5(3):413-4. doi: 10.4161/auto.5.3.7826. Epub 2009 Apr 13. Autophagy. 2009. PMID: 19197143

8

Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori.

Yang JC, Yang YF, Uang YS, Lin CJ, Wang TH. Yang JC, et al. Among authors: yang yf. Br J Clin Pharmacol. 2009 May;67(5):503-10. doi: 10.1111/j.1365-2125.2009.03393.x. Epub 2009 Feb 23. Br J Clin Pharmacol. 2009. PMID: 19552744 Free PMC article. Clinical Trial.

9

CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection.

Yang JC, Lin CJ. Yang JC, et al. Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):29-41. doi: 10.1517/17425250903386251. Expert Opin Drug Metab Toxicol. 2010. PMID: 19968574 Review.

10

Differential inhibitory effects of proton pump inhibitors on the metabolism and antiplatelet activities of clopidogrel and prasugrel.

Chen CH, Yang JC, Uang YS, Lin CJ. Chen CH, et al. Among authors: yang jc. Biopharm Drug Dispos. 2012 Jul;33(5):278-83. doi: 10.1002/bdd.1795. Epub 2012 Jun 29. Biopharm Drug Dispos. 2012. PMID: 22623337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,775 results

Search Page

Filters